Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
5,400
Employees5,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
5,400
Employees5,400

VRTX Key Statistics

Market cap
116.18B
Market cap116.18B
Price-Earnings ratio
-226.38
Price-Earnings ratio-226.38
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$452.44
High today$452.44
Low today
$452.44
Low today$452.44
Open price
$449.08
Open price$449.08
Volume
314.00
Volume314.00
52 Week high
$519.88
52 Week high$519.88
52 Week low
$346.29
52 Week low$346.29

VRTX News

Seeking Alpha 7d
Gilead, Vertex initiated as new big biotech buys at Citi

Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth...

Gilead, Vertex initiated as new big biotech buys at Citi

Analyst ratings

58%

of 38 ratings
Buy
57.9%
Hold
34.2%
Sell
7.9%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.